Ardan Pharma

Based on the discovery of the role of the transmembrane receptor Tmem176b in the regulation of tumour inflammation. It is developing compounds targeting this receptor to reactivate inflammation and boost anti-tumour activity, particularly in melanoma, colorectal cancer and chronic lymphatic leukaemia.